Xin-Ru Pan-Zhou - Concepedia

Author

Xin-Ru Pan-Zhou

Goldfinch Bio (United States)ORCID

Also Known As

X. Pan-Zhou, X.-R. Pan-Zhou, X.R. Pan-Zhou, Xin-Ru Pan-Zhou, Xin-ru Pan-Zhou

Publications

344

Citations

H-Index

Concepts

All Affiliations

Goldfinch Bio (United States)University of Alabama at Birmingham

About

Xin-Ru Pan-Zhou is an author at Goldfinch Bio (United States) specializing in medicine, pharmacology, and molecular pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	77
2	Engineering	1	1	25
3	Health Sciences	1	1	34
4	Biochemistry	1	1	34
5	Immunology	1	1	25

Xin-Ru Pan-Zhou

Publications

314

Citations

H-Index

Page 1

	Year	Citations
Differential Effects of Antiretroviral Nucleoside Analogs on Mitochondrial Function in HepG2 Cells Xin-Ru Pan-Zhou, Lixin Cui, Xiaojian Zhou, Antimicrobial Agents and Chemotherapy	2000	120
Discovery of a Potent and Selective TRPC5 Inhibitor, Efficacious in a Focal Segmental Glomerulosclerosis Model Maolin Yu, Mark W. Ledeboer, Matthew H. Daniels, ACS Medicinal Chemistry Letters	2019	58
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design Liron Walsh, John F. Reilly, C. Cornwall, Kidney International Reports	2021	36
Role of Human Liver P450s and Cytochrome b5 in the Reductive Metabolism of 3′-Azido-3′-deoxythymidine (AZT) to 3′-Amino-3′-deoxythymidine Xin-Ru Pan-Zhou, Erika Cretton-Scott, Xiaojian Zhou, Biochemical Pharmacology Molecular PharmacologyCytochrome B5BiochemistryReductive MetabolismLiver Physiology	1998	34
Transplanted organoids empower human preclinical assessment of drug candidate for the clinic Amy Westerling-Bui, Eva M. Fast, Thomas W. Soare, Science Advances EngineeringSolid Organ TransplantationImmunologyInvestigational New DrugPharmacodynamic Modeling	2022	25
Discovery and Optimization of Highly Selective Inhibitors of CDK5 Matthew H. Daniels, G. Malojcic, Susan L. Clugston, Journal of Medicinal Chemistry	2022	23
NM 283 has potent antiviral activity against genotype 1 chronic hepatitis C virus (HCV-1) infection in the chimpanzee David N. Standring, Robert E. Lanford, Teresa L. Wright, Journal of Hepatology Nm 283Hepatitis CViral HepatitisAntiviral ActivityMedicine	2003	18

Page 1